1. Describe the latest treatments of breast cancer. 

2. Identify the latest information on clinical relevance of biomarkers for breast cancer.

3. Describe recent changes with regards to HER2-directed therapy in breast cancer

4. Contextualize these HER2-directed therapy updates within current practice

5. Explain the use of immunotherapy in triple negative breast cancer

Session date: 
Wednesday, January 15, 2020 - 8:00am to 9:00am
Location: 
Room G5/119 CSC
600 Highland Avenue
Madison, WI 53792
United States
Presenter(s): 
Mark Burkard, MD
Amye J Tevaarwerk, MD
Ruth O'Regan, MD
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report